Breaking News Instant updates and real-time market news.

FMC

FMC Corporation

$118.22 /

-0.71 (-0.60%)

16:32
12/02/20
12/02
16:32
12/02/20
16:32

FMC Corporation raises dividend by 9% to 48c per share

FMC Corporation announced that its board of directors declared a regular quarterly dividend of 48 cents per share, payable on January 21 to shareholders of record as of the close of business on December 31.This represents a 9 percent increase over the Company's previous quarterly dividend, "Today's announcement reflects our policy to increase the dividend by at least the same rate of net income growth, as a part of our overall commitment to return excess cash to shareholders," said Andrew Sandifer, executive vice president and chief financial officer at FMC.

FMC FMC Corporation
$118.22 /

-0.71 (-0.60%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
FMC Corporation initiated with a Market Perform at Bernstein
11/18/20 BMO Capital
FMC Corporation price target raised to $124 from $120 at BMO Capital
11/18/20 KeyBanc
FMC Corporation price target raised to $137 from $121 at KeyBanc

TODAY'S FREE FLY STORIES

Downgrade
Wood Group downgraded to Underperform from Hold at Jefferies » 04:48
01/20/21
01/20
04:48
01/20/21
04:48
WDGJF

Wood Group

$0.00 /

+ (+0.00%)

Jefferies analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDGJF Wood Group
$0.00 /

+ (+0.00%)

01/19/21 Morgan Stanley
Wood Group downgraded to Equal Weight from Overweight at Morgan Stanley
01/15/21 Barclays
Wood Group downgraded to Equal Weight from Overweight at Barclays
01/08/21 Investec
Wood Group downgraded to Hold from Buy at Investec
01/06/21 JPMorgan
Wood Group price target raised to 410 GBp from 380 GBp at JPMorgan
Upgrade
Alstom upgraded to Buy from Hold at Jefferies » 04:46
01/20/21
01/20
04:46
01/20/21
04:46
ALSMY

Alstom

$0.00 /

+ (+0.00%)

Jefferies analyst Simon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALSMY Alstom
$0.00 /

+ (+0.00%)

ALSMY Alstom
$0.00 /

+ (+0.00%)

01/12/21 Deutsche Bank
Alstom price target raised to EUR 47 from EUR 45 at Deutsche Bank
12/11/20 Credit Suisse
Alstom upgraded to Outperform from Neutral at Credit Suisse
12/08/20 Morgan Stanley
Alstom price target raised to EUR 55 from EUR 51 at Morgan Stanley
12/01/20 Exane BNP Paribas
Alstom upgraded to Outperform from Neutral at Exane BNP Paribas
ALSMY Alstom
$0.00 /

+ (+0.00%)

Downgrade
Morgan Advanced Materials downgraded to Hold from Buy at Berenberg » 04:45
01/20/21
01/20
04:45
01/20/21
04:45
MCRUF

Morgan Advanced Materials

$0.00 /

+ (+0.00%)

Berenberg analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRUF Morgan Advanced Materials
$0.00 /

+ (+0.00%)

08/14/20 Berenberg
Morgan Advanced Materials price target raised to 270 GBp at Berenberg
07/14/20 RBC Capital
Morgan Advanced upgraded to Sector Perform from Underperform at RBC Capital
06/05/20 Jefferies
Jefferies reiterates Buy on Morgan Advanced Materials after 'resilient' update
04/03/20 Citi
Morgan Advanced Materials price target lowered to 275 GBp from 295 GBp
Upgrade
Saint-Gobain upgraded to Buy from Neutral at UBS » 04:43
01/20/21
01/20
04:43
01/20/21
04:43
CODYY

Saint-Gobain

$0.00 /

+ (+0.00%)

UBS analyst Gregor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CODYY Saint-Gobain
$0.00 /

+ (+0.00%)

01/14/21 Berenberg
Saint-Gobain initiated with a Sell at Berenberg
01/13/21 Citi
Saint-Gobain upgraded to Buy from Neutral at Citi
01/11/21 Deutsche Bank
Saint-Gobain price target raised to EUR 52 from EUR 48 at Deutsche Bank
01/08/21 JPMorgan
Saint-Gobain price target raised to EUR 48 from EUR 43 at JPMorgan
Downgrade
CaixaBank downgraded to Neutral from Buy at UBS » 04:42
01/20/21
01/20
04:42
01/20/21
04:42
CAIXY

CaixaBank

$0.00 /

+ (+0.00%)

UBS analyst Ignacio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAIXY CaixaBank
$0.00 /

+ (+0.00%)

CAIXY CaixaBank
$0.00 /

+ (+0.00%)

01/19/21 Barclays
CaixaBank price target raised to EUR 2.60 from EUR 2.50 at Barclays
01/19/21 Societe Generale
CaixaBank upgraded to Buy from Hold at Societe Generale
01/11/21 Deutsche Bank
CaixaBank price target raised to EUR 2.75 from EUR 2.70 at Deutsche Bank
12/14/20 JPMorgan
CaixaBank price target raised to EUR 2.35 from EUR 2.20 at JPMorgan
CAIXY CaixaBank
$0.00 /

+ (+0.00%)

Upgrade
Netflix upgraded to Buy from Neutral at UBS » 04:41
01/20/21
01/20
04:41
01/20/21
04:41
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

UBS analyst Eric Sheridan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

General news
FX Action: USD-CAD pegged a five-day low » 04:00
01/20/21
01/20
04:00
01/20/21
04:00

FX Action: USD-CAD pegged…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar has traded firmer for a third day » 03:50
01/20/21
01/20
03:50
01/20/21
03:50

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Asian Market Update: » 01:45
01/20/21
01/20
01:45
01/20/21
01:45

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
Pioneer Natural reinstated with a Buy at Goldman Sachs » 21:21
01/19/21
01/19
21:21
01/19/21
21:21
PXD

Pioneer Natural

$132.09 /

+4.62 (+3.62%)

Goldman Sachs analyst…

Goldman Sachs analyst Brian Singer reinstated coverage of Pioneer Natural Resources with a Buy rating and $166 price target following the closing of the Parsley Energy acquisition. The analyst has a favorable view on Pioneer's assets, saying they have the supply cost lowest among shale producers. The company's "deep" inventory can support 5% growth for more than a decade, Singer tells investors in a research note.

ShowHide Related Items >><<
PXD Pioneer Natural
$132.09 /

+4.62 (+3.62%)

PXD Pioneer Natural
$132.09 /

+4.62 (+3.62%)

01/15/21 Citi
Pioneer Natural price target raised to $154 from $130 at Citi
01/14/21 Barclays
Pioneer Natural price target raised to $153 from $151 at Barclays
01/14/21 Scotiabank
Chevron upgraded to Outperform from Sector Perform at Scotiabank
01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
PXD Pioneer Natural
$132.09 /

+4.62 (+3.62%)

PXD Pioneer Natural
$132.09 /

+4.62 (+3.62%)

PXD Pioneer Natural
$132.09 /

+4.62 (+3.62%)

PXD Pioneer Natural
$132.09 /

+4.62 (+3.62%)

Initiation
Polaris initiated with an Overweight at Morgan Stanley » 20:54
01/19/21
01/19
20:54
01/19/21
20:54
PII

Polaris

$113.25 /

+5.25 (+4.86%)

Morgan Stanley initiated…

Morgan Stanley initiated coverage of Polaris with an Overweight rating and $140 price target.

ShowHide Related Items >><<
PII Polaris
$113.25 /

+5.25 (+4.86%)

PII Polaris
$113.25 /

+5.25 (+4.86%)

01/19/21 Wedbush
Polaris price target raised to $126 from $116 at Wedbush
01/05/21 Baird
Polaris added to 2021 Best Idea list at Baird
11/27/20
Citi adds Polaris to 'Value Creators' SMID Focus List, removes Knight-Swift
11/20/20 Wedbush
Polaris removed from Best Ideas List at Wedbush
PII Polaris
$113.25 /

+5.25 (+4.86%)

PII Polaris
$113.25 /

+5.25 (+4.86%)

Syndicate
Document Security 6.67M share Spot Secondary priced at $3.60 » 20:40
01/19/21
01/19
20:40
01/19/21
20:40
DSS

Document Security

$5.48 /

-0.47 (-7.90%)

The deal priced below the…

The deal priced below the last closing price of $5.50. Aegis is acting as sole book running manager for the offering.

ShowHide Related Items >><<
DSS Document Security
$5.48 /

-0.47 (-7.90%)

DSS Document Security
$5.48 /

-0.47 (-7.90%)

06/24/20 Aegis
Document Security assumed with a Buy at Aegis
DSS Document Security
$5.48 /

-0.47 (-7.90%)

  • 28
    Jul
  • 02
    Jul
  • 22
    May
  • 21
    Feb
DSS Document Security
$5.48 /

-0.47 (-7.90%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/19/21
01/19
20:25
01/19/21
20:25
PG

Procter & Gamble

$133.56 /

-1.275 (-0.95%)

, UNH

UnitedHealth

$352.10 /

+0.995 (+0.28%)

, MS

Morgan Stanley

$74.99 /

-0.23 (-0.31%)

, USB

U.S. Bancorp

$48.05 /

-0.39 (-0.81%)

, BK

BNY Mellon

$45.81 /

+0.24 (+0.53%)

, FAST

Fastenal

$50.42 /

-0.08 (-0.16%)

, CFG

Citizens Financial

$40.83 /

+0.18 (+0.44%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Procter & Gamble (PG), consensus $1.51... UnitedHealth (UNH), consensus $2.41... Morgan Stanley (MS), consensus $1.27... U.S. Bancorp (USB), consensus 95c... Bank of New York Mellon (BK), consensus 91c... Fastenal (FAST), consensus 33c... Citizens Financial (CFG), consensus 91c.

ShowHide Related Items >><<
USB U.S. Bancorp
$48.05 /

-0.39 (-0.81%)

UNH UnitedHealth
$352.10 /

+0.995 (+0.28%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

MS Morgan Stanley
$74.99 /

-0.23 (-0.31%)

FAST Fastenal
$50.42 /

-0.08 (-0.16%)

CFG Citizens Financial
$40.83 /

+0.18 (+0.44%)

BK BNY Mellon
$45.81 /

+0.24 (+0.53%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

01/19/21 Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
01/13/21 Deutsche Bank
Procter & Gamble price target raised to $159 from $156 at Deutsche Bank
01/06/21 Evercore ISI
PepsiCo downgraded to In Line to reflect macro view at Evercore ISI
12/07/20 Wells Fargo
Colgate-Palmolive initiated with an Underweight at Wells Fargo
UNH UnitedHealth
$352.10 /

+0.995 (+0.28%)

01/07/21 Wells Fargo
Change Healthcare downgraded to Equal Weight from Overweight at Wells Fargo
01/07/21 Cowen
Change Healthcare downgraded to Market Perform from Outperform at Cowen
01/07/21 Deutsche Bank
UnitedHealth price target raised to $404 from $359 at Deutsche Bank
01/07/21 RBC Capital
Change Healthcare downgraded to Sector Perform from Outperform at RBC Capital
MS Morgan Stanley
$74.99 /

-0.23 (-0.31%)

01/11/21 Piper Sandler
Morgan Stanley price target raised to $76 from $54 at Piper Sandler
01/06/21 Deutsche Bank
Morgan Stanley price target raised to $68 from $53 at Deutsche Bank
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Barclays
Morgan Stanley upgraded to Overweight with $88 target at Barclays
USB U.S. Bancorp
$48.05 /

-0.39 (-0.81%)

01/07/21 Jefferies
U.S. Bancorp upgraded to Buy with $58 price target at Jefferies
01/07/21 BofA
U.S. Bancorp downgraded to Underperform from Neutral at BofA
01/07/21 Jefferies
U.S. Bancorp upgraded to Buy from Hold at Jefferies
01/06/21 Deutsche Bank
U.S. Bancorp price target raised to $55 from $46 at Deutsche Bank
BK BNY Mellon
$45.81 /

+0.24 (+0.53%)

01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Piper Sandler
BNY Mellon price target raised to $47 from $40 at Piper Sandler
01/05/21 Goldman Sachs
Northern Trust downgraded to Sell from Neutral at Goldman Sachs
FAST Fastenal
$50.42 /

-0.08 (-0.16%)

12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/16/20 Deutsche Bank
Fastenal downgraded to Hold from Buy at Deutsche Bank
10/15/20 Stephens
Fastenal resumed with an Overweight at Stephens
10/15/20 Argus
Fastenal price target raised to $52 from $43 at Argus
CFG Citizens Financial
$40.83 /

+0.18 (+0.44%)

01/12/21 UBS
UBS downgrades Citizens on revenue headwinds, Wells new top pick
01/11/21 UBS
Citizens Financial downgraded to Neutral from Buy at UBS
01/06/21 Deutsche Bank
Citizens Financial price target raised to $41 from $31 at Deutsche Bank
01/04/21 Barclays
Citizens Financial price target raised to $44 from $35 at Barclays
USB U.S. Bancorp
$48.05 /

-0.39 (-0.81%)

UNH UnitedHealth
$352.10 /

+0.995 (+0.28%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

MS Morgan Stanley
$74.99 /

-0.23 (-0.31%)

FAST Fastenal
$50.42 /

-0.08 (-0.16%)

CFG Citizens Financial
$40.83 /

+0.18 (+0.44%)

BK BNY Mellon
$45.81 /

+0.24 (+0.53%)

USB U.S. Bancorp
$48.05 /

-0.39 (-0.81%)

UNH UnitedHealth
$352.10 /

+0.995 (+0.28%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

MS Morgan Stanley
$74.99 /

-0.23 (-0.31%)

CFG Citizens Financial
$40.83 /

+0.18 (+0.44%)

BK BNY Mellon
$45.81 /

+0.24 (+0.53%)

USB U.S. Bancorp
$48.05 /

-0.39 (-0.81%)

UNH UnitedHealth
$352.10 /

+0.995 (+0.28%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

MS Morgan Stanley
$74.99 /

-0.23 (-0.31%)

FAST Fastenal
$50.42 /

-0.08 (-0.16%)

CFG Citizens Financial
$40.83 /

+0.18 (+0.44%)

BK BNY Mellon
$45.81 /

+0.24 (+0.53%)

USB U.S. Bancorp
$48.05 /

-0.39 (-0.81%)

UNH UnitedHealth
$352.10 /

+0.995 (+0.28%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

MS Morgan Stanley
$74.99 /

-0.23 (-0.31%)

Hot Stocks
Chewy CEO sells 127.8K shares of common stock » 19:44
01/19/21
01/19
19:44
01/19/21
19:44
CHWY

Chewy

$107.33 /

-0.72 (-0.67%)

In a regulatory filing,…

In a regulatory filing, Chewy disclosed that its CEO Sumit Singh sold 127.8K shares of common stock on January 15th in a total transaction size of $14.06M, reducing his stake by about 6%.

ShowHide Related Items >><<
CHWY Chewy
$107.33 /

-0.72 (-0.67%)

CHWY Chewy
$107.33 /

-0.72 (-0.67%)

01/19/21 Needham
Chewy price target raised to $120 from $110 at Needham
01/19/21 UBS
Chewy downgraded to Sell from Neutral at UBS
01/13/21 Credit Suisse
Chewy price target raised to $121 from $104 at Credit Suisse
01/04/21 Barclays
Chewy assumed with an Equal Weight at Barclays
CHWY Chewy
$107.33 /

-0.72 (-0.67%)

  • 17
    Sep
CHWY Chewy
$107.33 /

-0.72 (-0.67%)

CHWY Chewy
$107.33 /

-0.72 (-0.67%)

CHWY Chewy
$107.33 /

-0.72 (-0.67%)

Hot Stocks
Peloton CEO sells 100K shares of common stock » 19:43
01/19/21
01/19
19:43
01/19/21
19:43
PTON

Peloton

$150.29 /

-7.41 (-4.70%)

In a regulatory filing,…

In a regulatory filing, Peloton disclosed that its CEO Jphn Paul Foley sold 100K shares of common stock on January 15th in a total transaction size of $16.0M, reducing his stake by about 25%.

ShowHide Related Items >><<
PTON Peloton
$150.29 /

-7.41 (-4.70%)

PTON Peloton
$150.29 /

-7.41 (-4.70%)

01/19/21
Fly Intel: Top five analyst downgrades
01/19/21 UBS
Peloton downgraded to Sell from Neutral at UBS
01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Gordon Haskett
Peloton initiated with a Buy at Gordon Haskett
PTON Peloton
$150.29 /

-7.41 (-4.70%)

PTON Peloton
$150.29 /

-7.41 (-4.70%)

PTON Peloton
$150.29 /

-7.41 (-4.70%)

PTON Peloton
$150.29 /

-7.41 (-4.70%)

Hot Stocks
Guardant Health CEO sells 150K shares of common stock » 19:41
01/19/21
01/19
19:41
01/19/21
19:41
GH

Guardant Health

$159.96 /

+0.66 (+0.41%)

In a regulatory filing,…

In a regulatory filing, Guardant Health disclosed that its CEO Helmy Eltoukhy sold 150K shares of common stock on January 15th in a total transaction size of $23.8M, reducing his stake by about 4%.

ShowHide Related Items >><<
GH Guardant Health
$159.96 /

+0.66 (+0.41%)

GH Guardant Health
$159.96 /

+0.66 (+0.41%)

01/14/21 Canaccord
Natera price target raised to $125 from $112 at Canaccord
01/12/21 Canaccord
Guardant Health price target raised to $170 from $145 at Canaccord
01/11/21
Fly Intel: Top five analyst initiations
01/11/21 Stifel
Guardant Health initiated with a Buy at Stifel
GH Guardant Health
$159.96 /

+0.66 (+0.41%)

  • 07
    Oct
  • 02
    Jun
GH Guardant Health
$159.96 /

+0.66 (+0.41%)

Earnings
F.N.B. reports Q4 EPS 28c, consensus 24c » 19:09
01/19/21
01/19
19:09
01/19/21
19:09
FNB

F.N.B.

$11.09 /

+0.105 (+0.96%)

Reports Q4 net interest…

Reports Q4 net interest margin up 8bps to 2.87%. Reports Q4 Pre-provision net revenue $103.4M vs. $123.1M last year. Reports Q4: growth in total average loans was $2.4B, or 10.4%; total average deposits grew $4.1B, or 16.6%, primarily due to an increase in average non-interest-bearing deposits of $2.6B; net interest income increased $8.0M.

ShowHide Related Items >><<
FNB F.N.B.
$11.09 /

+0.105 (+0.96%)

FNB F.N.B.
$11.09 /

+0.105 (+0.96%)

11/25/20 Stephens
Stephens downgrades F.N.B. to Equal Weight on relative outlook
11/25/20 Stephens
F.N.B. downgraded to Equal Weight from Overweight at Stephens
FNB F.N.B.
$11.09 /

+0.105 (+0.96%)

Hot Stocks
Colfax unit DJO acquires Trilliant SUrgical » 19:06
01/19/21
01/19
19:06
01/19/21
19:06
CFX

Colfax

$39.58 /

+0.78 (+2.01%)

DJO, LLC, a subsidiary of…

DJO, LLC, a subsidiary of Colfax Corporation announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. The acquisition of Trilliant Surgical's "leading product technologies and clinical efficacy supports DJO's focused expansion into the adjacent high-growth $1B US foot and ankle market."

ShowHide Related Items >><<
CFX Colfax
$39.58 /

+0.78 (+2.01%)

CFX Colfax
$39.58 /

+0.78 (+2.01%)

01/13/21 Deutsche Bank
Colfax named 'Catalyst Call: Sell Idea' at Deutsche Bank
11/18/20 KeyBanc
Colfax price target raised to $44 from $36 at KeyBanc
11/09/20 UBS
Colfax upgraded to Buy from Neutral at UBS
09/15/20 UBS
Colfax initiated with a Neutral at UBS
CFX Colfax
$39.58 /

+0.78 (+2.01%)

Hot Stocks
Q BioMed granted Orphan Drug Designation for uttroside B » 18:50
01/19/21
01/19
18:50
01/19/21
18:50
QBIO

Q BioMed

$0.00 /

+ (+0.00%)

Q BioMed announced that…

Q BioMed announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for uttroside B for the treatment of hepatocellular carcinoma. Reference Link

ShowHide Related Items >><<
QBIO Q BioMed
$0.00 /

+ (+0.00%)

Hot Stocks
Logitech CEO: We're going to be right in the center of how people work » 18:45
01/19/21
01/19
18:45
01/19/21
18:45
LOGI

Logitech

$97.74 /

-3.21 (-3.18%)

In an interview on…

In an interview on CNBC's Mad Money, Bracken Darrell said digital content creation is the future and Logitech enables it. "We're right in the middle of many of our categories," he added. Logitech has always been an engineering-driven company and it's adding design to that, Darrell said.

ShowHide Related Items >><<
LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

12/21/20 Citi
Logitech price target raised to $110 from $105 at Citi
12/16/20 Morgan Stanley
Logitech price target raised to $106 from $100 at Morgan Stanley
11/12/20 Morgan Stanley
Logitech initiated with an Overweight at Morgan Stanley
11/05/20 Kepler Cheuvreux
Logitech upgraded to Buy from Hold at Kepler Cheuvreux
LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

LOGI Logitech
$97.74 /

-3.21 (-3.18%)

Hot Stocks
Nidec files patent infringement suit against Seagate » 18:32
01/19/21
01/19
18:32
01/19/21
18:32
NJDCY

Nidec

$0.00 /

+ (+0.00%)

, STX

Seagate

$61.20 /

+0.74 (+1.22%)

Nidec (NJDCY) filed a…

Nidec (NJDCY) filed a patent infringement lawsuit against Seagate (STX) and its affiliates on January 18, 2021 in the United States District Court for the District of Delaware, alleging that certain of Seagate products infringe Nidec-owned U.S. patents related to hard disk drive inventions. Nidec has expanded its HDD-business all over the world, and views its intellectual property as a significantly valuable corporate asset. Nidec will continue to strictly and properly pursue the protection of its intellectual property rights whenever infringement is identified.

ShowHide Related Items >><<
STX Seagate
$61.20 /

+0.74 (+1.22%)

NJDCY Nidec
$0.00 /

+ (+0.00%)

STX Seagate
$61.20 /

+0.74 (+1.22%)

01/19/21 Northland
Seagate price target raised to $72 from $65 at Northland
01/19/21 Loop Capital
Seagate price target raised to $70 from $60 at Loop Capital
12/31/20 KeyBanc
Industry data points to flat monthly contract pricing for DRAM, says KeyBanc
12/28/20 Mizuho
Seagate price target raised to $65 from $54 at Mizuho
STX Seagate
$61.20 /

+0.74 (+1.22%)

STX Seagate
$61.20 /

+0.74 (+1.22%)

STX Seagate
$61.20 /

+0.74 (+1.22%)

Earnings
Azek sees Q1 adjusted EBITDA $46.2M-$51.1M vs. $33.8M last year » 18:18
01/19/21
01/19
18:18
01/19/21
18:18
AZEK

Azek

$42.25 /

+1.045 (+2.54%)

Sees Q1 net income…

Sees Q1 net income $8.9M-$11.5M, compared to a loss of $9.8M in the same period last year. The company added, "This increase in net income was primarily due to higher sales in our Residential segment, improved gross margins and lower interest expense, partially offset by higher selling, general and administrative expenses."

ShowHide Related Items >><<
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

01/13/21 BMO Capital
Azek initiated with an Outperform at BMO Capital
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/04/20 DA Davidson
Azek price target raised to $39 from $33 at DA Davidson
12/04/20 B. Riley Securities
Azek price target raised to $46 from $43 at B. Riley Securities
AZEK Azek
$42.25 /

+1.045 (+2.54%)

  • 22
    Jan
  • 11
    Sep
  • 12
    Jun
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

Hot Stocks
Netflix says 'super proud' of free cash flow » 18:15
01/19/21
01/19
18:15
01/19/21
18:15
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Says will remain…

Says will remain "disciplined steward" of capital, but will continue to invest aggressively in growth opportunities. Says customer retention has improved from last year. Says members are willing to pay more for great stories, which gets us "fired up" about increasing rates. Says feel good about the competitive dynamic relative to Disney (DIS) given the higher ARPU. Comments taken from Q4 earnings conference call.

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Earnings
Azek sees Q1 revenue $209.1M-$213.4M, consensus $201.6M » 18:10
01/19/21
01/19
18:10
01/19/21
18:10
AZEK

Azek

$42.25 /

+1.045 (+2.54%)

Q1 revenue outlook…

Q1 revenue outlook compares with $166.0M last year, representing an increase of 26%-29%, respectively. The company said, "The increase in our consolidated net sales reflects estimated net sales from our Residential segment of between $182.9M-$186.6M for the three months ended December 31, as compared to $135.7M for the Q1 of FY19, with such increase primarily due to higher organic net sales related to our decking, railing, accessories and exteriors product categories as well as favorable operational execution whereby the first phase of our capacity expansion plan came online faster than planned during the quarter. Demand trends remained strong across our Residential segment channel partners during the quarter. The increase in our net sales also reflects estimated net sales from our Commercial segment of between $26.2-$26.8M, as compared to $30.4M for the three months ended December 31, 2019, with such decrease primarily due to declining sales in our Scranton Products and Vycom businesses as the effects of COVID-19 continue to impact certain end markets."

ShowHide Related Items >><<
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

01/13/21 BMO Capital
Azek initiated with an Outperform at BMO Capital
12/31/20 William Blair
Azek, Trex among Blair's top Specialty Distribution ideas for 2021
12/04/20 DA Davidson
Azek price target raised to $39 from $33 at DA Davidson
12/04/20 B. Riley Securities
Azek price target raised to $46 from $43 at B. Riley Securities
AZEK Azek
$42.25 /

+1.045 (+2.54%)

  • 22
    Jan
  • 11
    Sep
  • 12
    Jun
AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

AZEK Azek
$42.25 /

+1.045 (+2.54%)

Hot Stocks
Netflix says not necessarily through the 'pull forward' of 2020 » 18:08
01/19/21
01/19
18:08
01/19/21
18:08
NFLX

Netflix

$501.85 /

+3.9 (+0.78%)

Says there is "so…

Says there is "so much uncertainty right now - more uncertain than we have ever seen". Says still seeing strong underlying growth metrics. Says there is too much uncertainty in the business to provide a full-year guide, but feel "very good" about long-term trajectory. Says viewing trends are similar around the world, seeing growth everywhere. Some markets are further along in business maturation. Says Netflix still under 10% of TV viewing, would like to earn more viewing time share. Comments taken from Q4 earnings conference call.

ShowHide Related Items >><<
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

01/19/21 JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

NFLX Netflix
$501.85 /

+3.9 (+0.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.